Ground-breaking research

Medtech spin-out Invizius in Fierce 15’s ones to watch

Invizius H-Guard


A Scottish medical technology enterprise helping to improve the effectiveness of devices used in treatment has been included in a list of the most promising private companies in the industry. 

Invizius, a spin out from Edinburgh University, has developed an ‘invisible cloak’ that prevents the deadly complications that result when medical devices are rejected. It has been named as one of 2018’s Fierce 15 med tech companies to watch.

The company led ground-breaking research into how deadly bacteria manage to ‘hide’ from the human immune system. Its H-Guard product replicates bacteria’s behaviour and is being developed into a suite of products that integrate with existing treatments. 

Invizius’s first application targets the blood filter used in kidney dialysis, promising to meet a massive and desperate unmet need among almost three million patients with kidney failure.

H-Guard is also being developed to help millions of patients in critical care, or who undergo open heart surgery, who suffer from complications after being hooked up to heart and lung machines.

Invizius announced £500,000 of investment from Mercia Fund Managers in May last year, shortly after the company was formed with the help of Edinburgh Innovations, the University of Edinburgh’s commercialisation service. 

Richard Boyd, CEO of Invizius, said: “The team at Invizius is absolutely delighted that our innovation and global ambition are receiving international recognition as one of the Fierce 15, and this adds to the momentum the business is building.

“We are excited and motivated by the potential of H-Guard to address decades-long shortcomings in the treatment of millions of patients worldwide.”

The Fierce 15 celebrates the spirit of being “fierce” – championing innovation and creativity, even in the face of intense competition. This is FierceMedTech’s seventh annual Fierce 15 selection.

An internationally recognised daily report reaching a network of over 90,000 med tech industry professionals, FierceMedTech provides subscribers with an authoritative analysis of the day’s top stories.

Every year FierceMedTech evaluates hundreds of private companies from around the world for its annual Fierce 15 list, which is based on a variety of factors such as the strength of its technology, partnerships, venture backers and a competitive market position.

Leave a Reply

Your email address will not be published. Required fields are marked as *

This site uses Akismet to reduce spam. Learn how your comment data is processed.